Safe Harbor Protection: Acadia Pharms., Inc. v. Aurobindo Pharma Ltd.
In Acadia Pharms., Inc. v. Aurobindo Pharma Ltd., No. 20-985-GBW (D. Del. Dec. 2023), the district court granted Acadia’s motion for summary judgment of no invalidity for obviousness-type double patenting. The asserted patent was not a proper obviousness-type double patenting reference and the safe harbor of 35 U.S.C. §121 applied to protect the original application.
Originally published at finnegan.com
Citation
Adriana L. Burgy Stacy Lewis, Safe Harbor Protection: Acadia Pharms., Inc. v. Aurobindo Pharma Ltd., Prosecution First Blog (February 9, 2024) [The Library at LexBlog, LEX-WK-Y7JJWVDY, lexpid.org/Y7JJWVDY]